Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

From Teriparatide to Pembrolizumab: CDSCO Clears Import of r-DNA Drugs via CT-18 Route

Susmita Roy26 Jan 2026 1:58 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and December 2025 for...

CDSCO Panel Grants Go Ahead for Levim Lifetech's Phase I/III Teriparatide Trial

Susmita Roy26 Jan 2026 1:46 PM IST

New Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of permission to Levim...

Macleods Gets CDSCO Panel Nod to Conduct BE Studies for Semaglutide Prefilled Pens

Susmita Roy25 Jan 2026 11:36 PM IST

New Delhi: Accepting the toxicity data submitted by Macleods Pharmaceuticals, the Subject Expert Committee (SEC) functioning under the Central Drugs...

CDSCO Finds 93 Medicines Samples Substandard, Key Antibiotics, Chronic Drugs Affected

Susmita Roy25 Jan 2026 3:00 PM IST

New Delhi: Highlighting continuing concerns over drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control Organisation...

No Monopoly Over Alphabets: Delhi HC Rejects Alkem's 'A TO Z' Trademark Claim

Susmita Roy24 Jan 2026 6:13 PM IST

New Delhi: In a significant ruling for trademark law, the Delhi High Court has held that no company can monopolize common expressions or letters of...

CDSCO Clears Over 100 rDNA Drugs and Biologics Between 2020-25, Boosting Access to Advanced Therapies

Susmita Roy23 Jan 2026 5:09 PM IST

New Delhi: India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA...

CDSCO Flags 7 Batches of Popular Medicines as Purportedly Spurious in December

Susmita Roy23 Jan 2026 3:51 PM IST

New Delhi: In a disclosure that raises serious concerns over drug authenticity and patient safety, the Central Drugs Standard Control Organisation...

CDSCO Declares 74 Medicines, APIs and Devices Samples Not of Standard Quality in December

CDSCO Flags 74 Drugs, Devices Samples as NSQ in December: Zerodol-SP, Defcort, Telmisartan, Amikacin Among Failed Products

Susmita Roy22 Jan 2026 7:18 PM IST

New Delhi: As part of a nationwide quality surveillance drive, the Central Drugs Standard Control Organisation (CDSCO) has flagged 74 drugs,...

IVF specialist moves Delhi HC against blanket ban on frozen embryo adoption, court seeks centres response

Japanese Company Fails to Secure Indian Patent for Cancer Detection Using Nematodes

Susmita Roy20 Jan 2026 9:56 PM IST

New Delhi: In a significant ruling interpreting the scope of patent exclusion for diagnostic methods in India, the Delhi High Court has dismissed an...

Alcon India Gets Rs 25 Cr Tax Relief as ITAT Bengaluru Quashes Advertising, Marketing and Promotion Adjustments

Susmita Roy19 Jan 2026 10:00 PM IST

New Delhi: In a significant ruling with implications for multinational subsidiaries operating in India, the Income Tax Appellate Tribunal (ITAT),...

Nearly 49% Pharmacist Posts Vacant in Haryana Govt Hospitals, Patient Safety at Risk

Susmita Roy19 Jan 2026 7:00 PM IST

New Delhi: Patients' safety in Haryana's government hospitals is facing a serious risk as the state grapples with an acute shortage of pharmacists,...

CDSCO to Reject Long-Pending SUGAM Applications After 30 Days for Non-Response to Queries

Susmita Roy18 Jan 2026 5:58 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has announced that it will dispose of and reject long-pending applications...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok